1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Bispecific antibodies targeting CD40 and tumor-associated antigens promote cross-priming of T cells resulting in an antitumor response superior to monospecific antibodies
Hägerbrand, Karin LU ; Varas, Laura LU ; Deronic, Adnan LU ; Nyesiga, Barnabas ; Sundstedt, Anette LU ; Ljung, Lill ; Sakellariou, Christina LU
; Werchau, Doreen
; Thagesson, Mia
and Gomez Jimenez, David
LU
, et al.
(2022)
In Journal for ImmunoTherapy of Cancer
10(11).
- Contribution to journal › Article
- 2004
-
Mark
A novel FISH assay for SS18-SSX fusion type in synovial sarcoma
- Contribution to journal › Article
- 1999
-
Mark
Immunologic proliferation marker Ki-S2 as prognostic indicator for lymph node-negative breast cancer
Rudolph, P ; Alm, P LU ; Heidebrecht, H J ; Bolte, H ; Ratjen, V ; Baldetorp, B LU ; Fernö, M LU ; Olsson, H LU
and Parwaresch, R
(1999)
In Journal of the National Cancer Institute
91(3).
p.8-271
- Contribution to journal › Article
-
Mark
Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas : prognostic implications
Rudolph, P ; Olsson, Håkan LU
; Bonatz, G
; Ratjen, V
; Bolte, H
; Baldetorp, B
LU
; Fernö, M
LU
; Parwaresch, R
and Alm, P
LU
(1999)
In Journal of Pathology
187(2).
p.16-207
- Contribution to journal › Article